Biolife Solutions Stock Analysis

BioLife Stock Analysis Notes

About 98.0% of the company shares are held by institutions such as insurance companies. The book value of BioLife Solutions was currently reported as 7.44. The company has Price/Earnings (P/E) ratio of 173.59. BioLife Solutions recorded a loss per share of 0.25. The entity had not issued any dividends in recent years. The firm had 1:14 split on the 29th of January 2014. BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. BioLife Solutions, Inc. was incorporated in 1987 and is headquartered in Bothell, Washington. Biolife Solutions operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 432 people. For more info on BioLife Solutions please contact Michael Rice at 425 402 1400 or go to https://www.biolifesolutions.com.

BioLife Solutions Investment Alerts

BioLife Solutions Upcoming and Recent Events

BioLife Largest EPS Surprises

View All Earnings Estimates

BioLife Solutions Environmental, Social, and Governance (ESG) Scores

BioLife Stock Institutional Investors

Note, although BioLife Solutions' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

BioLife Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.17 B.

BioLife Profitablity

The company has Profit Margin (PM) of (0.25) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.4) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.4.

Management Efficiency

BioLife Solutions has return on total asset (ROA) of (0.011) % which means that it has lost $0.011 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0332) %, meaning that it created substantial loss on money invested by shareholders. BioLife Solutions' management efficiency ratios could be used to measure how well BioLife Solutions manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.12 in 2025. Return On Capital Employed is likely to drop to -0.02 in 2025. At this time, BioLife Solutions' Total Assets are comparatively stable compared to the past year. Non Current Assets Total is likely to gain to about 263.3 M in 2025, whereas Return On Tangible Assets are likely to drop (0.12) in 2025.

Technical Drivers

As of the 23rd of March, BioLife Solutions shows the Risk Adjusted Performance of (0.01), standard deviation of 2.78, and Mean Deviation of 2.19. BioLife Solutions technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm BioLife Solutions variance and potential upside to decide if BioLife Solutions is priced correctly, providing market reflects its regular price of 24.99 per share. Given that BioLife Solutions has information ratio of (0), we suggest you to validate BioLife Solutions's prevailing market performance to make sure the company can sustain itself at a future point.

BioLife Solutions Price Movement Analysis

BioLife Solutions Insider Trading Activities

BioLife Solutions Outstanding Bonds

BioLife Solutions Predictive Daily Indicators

BioLife Solutions Corporate Filings

BioLife Solutions Forecast Models

BioLife Solutions' time-series forecasting models are one of many BioLife Solutions' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary BioLife Solutions' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how BioLife Solutions prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling BioLife shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as BioLife Solutions. By using and applying BioLife Stock analysis, traders can create a robust methodology for identifying BioLife entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. BioLife analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. BioLife analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

BioLife Solutions stock analysis indicators help investors evaluate how BioLife Solutions stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading BioLife Solutions shares will generate the highest return on investment. By understating and applying BioLife Solutions stock analysis, traders can identify BioLife Solutions position entry and exit signals to maximize returns.

When running BioLife Solutions' price analysis, check to measure BioLife Solutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioLife Solutions is operating at the current time. Most of BioLife Solutions' value examination focuses on studying past and present price action to predict the probability of BioLife Solutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioLife Solutions' price. Additionally, you may evaluate how the addition of BioLife Solutions to your portfolios can decrease your overall portfolio volatility.